NFE2L2 and lung carcinoma: Similarly, chalcone derivatives such as 4-methoxy-chalcone (4-MC), hesperidin methylchalcone, and neohesperidin dihydrochalcone target Nrf2, reducing the expression of the downstream antioxidant gene NQO1 and promoting ROS generation, thereby sensitizing lung cancer cells to chemotherapy 103.